Patent Assignment
Reel/Frame 057447/0911
Assignment of Assignor's Interest
Recorded: 2021-09-10
Pages: 8
Assignor
CLOUDBREAK THERAPEUTICS, LLC
Executed: 2021-08-31
Assignee
ADS THERAPEUTICS LLC
15615 ALTON PARKWAY, SUITE 450, IRVINE, CALIFORNIA, 92618-3308
Covered Properties
(6)
Compositions and Methods of Using Nintedanib for Improving Glaucoma Surgery Success
PCT:
PCT/US2017/034792 ↗
Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization
PCT:
PCT/US2017/034795 ↗
Compositions and Methods of Using Nintedanib for Improving Glaucoma Surgery Success
Compositions and Methods of Using Nintedanib for Improving Glaucoma Surgery Success
Methods for Improving Corneal Transplant Success and Treatment of Other Front of the Eye Diseases with Neovascularization Component
Application:
62/344,870 →
Methods for Improving the Success Rate of Glaucoma Surgery and Neovascular Glaucoma Treatment
Application:
62/344,878 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 1, 2016
From: NI, JINSONG; YANG, RONG
To: CLOUDBREAK THERAPEUTICS, LLC
Reel/Frame 039066/0472 →
Assignment of Assignor's Interest
Jul 7, 2016
From: NI, JINSONG; YANG, RONG
To: CLOUDBREAK THERAPEUTICS, LLC
Reel/Frame 039101/0766 →
Assignment of Assignor's Interest
May 3, 2019
From: NI, JINSONG; YANG, RONG
To: CLOUDBREAK THERAPEUTICS, LLC
Reel/Frame 049077/0872 →
Assignment of Assignor's Interest
Apr 10, 2020
From: NI, JINSONG; YANG, RONG
To: CLOUDBREAK THERAPEUTICS, LLC
Reel/Frame 052368/0355 →
Assignment of Assignor's Interest
Apr 10, 2020
From: NI, JINSONG; YANG, RONG
To: CLOUDBREAK THERAPEUTICS, LLC
Reel/Frame 052368/0469 →